Kawai H, Nomoto M, Suda T, Kamimura K, Tsuchiya A, Tamura Y, Yano M, Takamura M, Igarashi M, Wakai T, Yamagiwa S, Matsuda Y, Ohkoshi S, Kurosaki I, Shirai Y, Okada M, Aoyagi Y. Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis. World J Hepatol 2011; 3(1): 15-23 [PMID: 21307983 DOI: 10.4254/wjh.v3.i1.15]
Corresponding Author of This Article
Hirokazu Kawai, MD, PhD, Department of Clinical Laboratory, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-dori Chuo-ku, Niigata 951-8510, Japan. kawaih@med.niigata-u.ac.jp
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Hirokazu Kawai, Department of Clinical Laboratory, Niigata University Medical and Dental Hospital, Niigata 951-8510, Japan
Minoru Nomoto, Takeshi Suda, Kenya Kamimura, Atsunori Tsuchiya, Yasushi Tamura, Masahiko Yano, Masaaki Takamura, Masato Igarashi, Satoshi Yamagiwa, Shogo Ohkoshi, Yutaka Aoyagi, Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
Toshifumi Wakai, Isao Kurosaki, Yoshio Shirai, Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
Yasunobu Matsuda, Department of Medical Technology, Niigata University Graduate School of Health Sciences, Niigata 951-8518, Japan
Masahiko Okada, Division of Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan
Author contributions: Kawai H is a physician who drafted the manuscript and revised critically for content; Nomoto M contributed to the pathological analysis; Suda T was a major contributor to writing the manuscript; Kamimura K, Tsuchiya A, Tamura Y, Yano M, Takamura M, Igarashi M, Yamagiwa S, Matsuda Y, Ohkoshi S and Aoyagi Y are physicians who have treated the patients and analyzed the data; Wakai T, Kurosaki I and Shirai Y are surgeons who treated the patients; and Okada M contributed to the analysis of the data.
Correspondence to: Hirokazu Kawai, MD, PhD, Department of Clinical Laboratory, Niigata University Medical and Dental Hospital, 1-757 Asahimachi-dori Chuo-ku, Niigata 951-8510, Japan. kawaih@med.niigata-u.ac.jp
Telephone: +81-25-2272336 Fax: +81-25-2230996
Received: September 3, 2010 Revised: November 11, 2010 Accepted: November 18, 2010 Published online: January 27, 2011
Abstract
AIM: To reveal the manner of hepatocellular carcinoma (HCC) development in patients with nonalcoholic steatohepatitis (NASH) focusing on multicentric occurrence (MO) of HCC.
METHODS: We compared clinicopathological characteristics between patients with and without MO of HCC arising from NASH background. The clinical features were implicated with reference to the literature available.
RESULTS: MO of HCC was identified with histological proof in 4 out of 12 patients with NASH-related HCC (2 males and 2 females). One patient had synchronous MO; an advanced HCC, two well-differentiated HCCs and a dysplastic nodule, followed by the development of metachronous MO of HCC. The other three patients had multiple advanced HCCs accompanied by a well-differentiated HCC or a dysplastic nodule. Of these three patients, one had synchronous MO, one had metachronous MO and the other had both synchronous and metachronous MO. There were no obvious differences between the patients with or without MO in terms of liver function tests, tumor markers and anatomical extent of HCC. On the other hand, all four patients with MO of HCC were older than 70 years old and had the comorbidities of obesity, type 2 diabetes mellitus (T2DM), hypertension and cirrhosis. Although these conditions were not limited to MO of HCC, all the conditions were met in only one of eight patients without MO of HCC. Thus, concurrence of these conditions may be a predisposing situation to synchronous MO of HCC. In particular, old age, T2DM and cirrhosis were suggested to be prerequisite for MO because these factors were depicted in common among two other cases with MO of HCC under NASH in the literature.
CONCLUSION: The putative predisposing factors and necessary preconditions for synchronous MO of HCC in NASH were suggested in this study. Further investigations are required to clarify the accurate prevalence and predictors of MO to establish better strategies for treatment and prevention leading to the prognostic improvement in NASH.
